• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Clinical characteristics of patients with confirmed and asymptomatic SARS-CoV-2 infection in China

tetano

Editor, Senior Moderator
PLoS One


. 2022 Aug 23;17(8):e0273150.
doi: 10.1371/journal.pone.0273150. eCollection 2022.
Clinical characteristics of patients with confirmed and asymptomatic SARS-CoV-2 infection in China


Zongren Li[SUP] 1 2 [/SUP], Qin Zhong[SUP] 2 [/SUP], Wenyuan Li[SUP] 3 [/SUP], Dawei Zhang[SUP] 4 [/SUP], Wenjun Wang[SUP] 5 [/SUP], Feifei Yang[SUP] 6 [/SUP], Kunlun He[SUP] 1 2 5 [/SUP]



Affiliations

Abstract

Objective: To examine the clinical characteristics of patients with asymptomatic novel coronavirus disease 2019 (COVID-19) and compare them with those of patients with mild disease.
Design: A retrospective cohort study.
Setting: Multiple medical centers in Wuhan, Hubei, China.
Participants: A total of 3,263 patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection between February 4, 2020, and April 15, 2020.
Main outcome measures: Patient demographic characteristics, medical history, vital signs, and laboratory and chest computed tomography (CT) findings.
Results: A total of 3,173 and 90 patients with mild and moderate, and asymptomatic COVID-19, respectively, were included. A total of 575 (18.2%) symptomatic patients and 4 (4.4%) asymptomatic patients developed the severe illness. All asymptomatic patients recovered; no deaths were observed in this group. The median duration of viral shedding in asymptomatic patients was 17 (interquartile range, 9.25-25) days. Patients with higher levels of ultrasensitive C-reactive protein (odds ratio [OR] = 1.025, 95% confidence interval [CI], 1.01-1.04), lower red blood cell volume distribution width (OR = 0.68, 95% CI 0.51-0.88), lower creatine kinase Isoenzyme(0.94, 0.89-0.98) levels, or lower lesion ratio (OR = 0.01, 95% CI 0.00-0.33) at admission were more likely than their counterparts to have asymptomatic disease.
Conclusions: Patients with younger ages and fewer comorbidities are more likely to be asymptomatic. Asymptomatic patients had similar laboratory characteristics and longer virus shedding time than symptomatic patients; screen and isolation during their infection were helpful to reduce the risk of SARS-CoV-2 transmission.
 
Back
Top Bottom